UK markets closed

ResMed Inc. (RMD)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
208.30+6.24 (+3.09%)
At close: 04:00PM EDT
208.50 +0.20 (+0.10%)
After hours: 07:52PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2021
30/06/2020
30/06/2019
30/06/2018
Total revenue
3,539,493
3,196,825
2,957,013
2,606,572
2,340,196
Cost of revenue
1,546,991
1,357,725
1,239,227
1,069,987
978,032
Gross profit
1,992,502
1,839,100
1,717,786
1,536,585
1,362,164
Operating expenses
Research development
249,133
225,284
201,946
180,651
155,149
Selling general and administrative
725,966
670,387
676,689
645,010
600,369
Total operating expenses
1,005,975
926,749
908,727
900,599
801,901
Operating income or loss
986,527
912,351
809,059
635,986
560,263
Interest expense
-
23,989
40,377
36,156
28,355
Total other income/expenses net
-2,866
-5,062
-36,615
-83,282
-26,974
Income before tax
961,605
883,662
733,088
518,847
521,312
Income tax expense
182,129
409,157
111,414
114,255
205,724
Income from continuing operations
779,476
474,505
621,674
404,592
315,588
Net income
779,476
474,505
621,674
404,592
315,588
Net income available to common shareholders
779,476
474,505
621,674
404,592
315,588
Basic EPS
-
3.27
4.31
2.83
2.21
Diluted EPS
-
3.24
4.27
2.80
2.19
Basic average shares
-
145,313
144,338
143,111
142,764
Diluted average shares
-
146,451
145,652
144,484
143,987
EBITDA
-
1,099,169
954,838
705,798
669,627